Related references
Note: Only part of the references are listed.Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
Troy G. Seelhammer et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2021)
2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients
Roberto Lorusso et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2021)
Coronavirus Disease 2019-Associated Coagulopathy
Giuseppe Lippi et al.
MAYO CLINIC PROCEEDINGS (2021)
Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation
Haya Kaseer et al.
JOURNAL OF CARDIAC SURGERY (2020)
Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing
Jun Teruya et al.
THROMBOSIS RESEARCH (2020)
Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation*
Mohammed Hamzah et al.
PEDIATRIC CRITICAL CARE MEDICINE (2020)
A comparison of bivalirudin and heparin for patients on extracorporeal membrane oxygenation
Matthew A. Brown et al.
THROMBOSIS RESEARCH (2020)
Prospective Exploratory Experience With Bivalirudin Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation
Lindsay M. Ryerson et al.
PEDIATRIC CRITICAL CARE MEDICINE (2020)
Bivalirudin and ECLS: Commentary and Considerations
Troy G. Seelhammer et al.
ASAIO JOURNAL (2019)
Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation
James Thomas et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation
Theodore J. Berei et al.
ASAIO JOURNAL (2018)
Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks between Inflammation and Coagulation
Frantzeska Frantzeskaki et al.
RESPIRATION (2017)
Bivalirudin for Alternative Anticoagulation in Extracorporeal Membrane Oxygenation: A Systematic Review
Filippo Sanfilippo et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2017)
Extracorporeal Life Support Organization Registry International Report 2016
Ravi R. Thiagarajan et al.
ASAIO JOURNAL (2017)
Association of Bleeding and Thrombosis With Outcome in Extracorporeal Life Support
Heidi J. Dalton et al.
PEDIATRIC CRITICAL CARE MEDICINE (2015)
The coagulation system and its function in early immune defense
Tom van der Poll et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Bivalirudin Versus Heparin as an Anticoagulant During Extracorporeal Membrane Oxygenation: A Case-Control Study
Marina Pieri et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2013)
Developmental hemostasis: age-specific differences in the levels of hemostatic proteins
C. Attard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Direct thrombin inhibitors
Catherine J. Lee et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation
Marco Ranucci et al.
CRITICAL CARE (2011)
Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support
D. C. Alexander et al.
THROMBOSIS RESEARCH (2010)
Pharmacological strategies for inhibition of thrombin activity
S. Alban
CURRENT PHARMACEUTICAL DESIGN (2008)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
Bivalent direct thrombin inhibitors: hirudin and bivalirudin
TE Warkentin
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2004)
Share Paper
